LU Innovation System AB (LUIS) has since 1999 been involved in spinning out 69 companies based on research from Lund University. The portfolio has now increased by the investment in SenzaGen AB. “We have a strong connection to Lund University and the investment by LUIS acknowledges our work and provides us with the ability to […]
About Hanna Frykman
This author has yet to write their bio.Meanwhile lets just say that we are proud Hanna Frykman contributed a whooping 85 entries.
Entries by Hanna Frykman
“The project for which Dr. Johansson was awarded, the Lush Prize Young Researcher Award, describes the development and use of the novel test method GARD – Genomic Allergen Rapid Detection, an assay for assessment of chemical sensitizers. …GARD utilises an in vitro model of so-called dendritic cells, a central player in the human immune system. […]
-We are entering into a very exciting commercial phase and are happy to be able to engage board members with international experience from our target markets, says Prof. Carl Borrebaeck, chairman of the board of SenzaGen. Carl-Henric Nilsson holds a PhD and M.Sc. in Industrial management, and is Associate Professor at Lund University, School of […]
We are very happy to have been able to recruit Dr. Malmborg, who has extensive experience from commercialization of academic results, financial markets and business developments says Prof.Carl Borrebaeck, chairman of the Board of SenzaGen. Anki Malmborg Hager has more than 20 years´ experience in both pharmaceutical and biotech companies that are spin-offs from the […]
Toxicol Sci. 2014 Jun;139(2):362-70. doi: 10.1093/toxsci/kfu046. Epub 2014 Mar 27. Johansson H., Rydnert F., Kuehnl J., Schepky A., Borrebaeck C.A.K., Lindstedt M. Abstract Chemical sensitization is an adverse immunologic response to chemical substances, inducing hypersensitivity in exposed individuals. Identifying chemical sensitizers is of great importance for chemical, pharmaceutical, and cosmetic industries, in order to prevent […]
Immunology. 2014 Jun;142(2):279-88. doi: 10.1111/imm.12252. Lundberg K., Rydnert F, Greiff L, Lindstedt M. Abstract Dendritic cells (DCs) operate as the link between innate and adaptive immunity. Their expression of pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and C-type lectin receptors (CLRs), enables antigen recognition and mediates appropriate immune responses. Distinct subsets of human […]
BMC Genomics. 2014 May 16;15:379. doi: 10.1186/1471-2164-15-379. Forreryd A., Johansson H., Albrekt A.S., Lindstedt M Abstract BACKGROUND: Allergic contact dermatitis (ACD) develops upon exposure to certain chemical compounds termed skin sensitizers. To reduce the occurrence of skin sensitizers, chemicals are regularly screened for their capacity to induce sensitization. The recently developed Genomic Allergen Rapid Detection […]
SenzaGen is proud to be awarded financial support by IKS Accelerator.
Basic Clin Pharmacol Toxicol. 2014 Jul;115(1):110-7. doi: 10.1111/bcpt.12199. Epub 2014 Feb 18. Johansson H., Lindstedt M. Abstract Regulatory frameworks within the European Union demand that chemical substances are investigated for their ability to induce sensitization, an adverse health effect caused by the human immune system in response to chemical exposure. A recent ban on the […]
BMC Pharmacol Toxicol. 2014 Feb 11;15:5. doi: 10.1186/2050-6511-15-5. Albrekt A.S., Johansson H., Borrebaeck C.A.K., Lindstedt M. Abstract BACKGROUND: Due to the recent European legislations posing a ban of animal tests for safety assessment within the cosmetic industry, development of in vitro alternatives for assessment of skin sensitization is highly prioritized. To date, proposed in vitro […]